Affiliation:
1. Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment; Far Eastern Federal University, Medical Center
2. Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment
Abstract
Introduction. Cardiovascular disease is the leading cause of morbidity, disability and mortality in modern society. Coronary artery disease (CAD) and chronic obstructive pulmonary disease (COPD) are the most common comorbid pathology that worsens the quality of life and prospective prognosis of patients.Aim. The literature review is focused on postoperative outcomes of patients with COPD undergoing coronary artery bypass grafting surgery (CABG).Results. The review presents national and international data the prevalence of COPD in patients having CABG. The issues of risk stratification of comorbid patients in cardiac surgery are considered. It is shown that patients with CAD in combination with COPD are more at risk of various complications after CABG. COPD increases the chances of a complicated course of the in-hospital period by 2.1 times and risk of death in the long-term period after CAPG by 1.8 times. Patients with COPD are at a higher risk of developing postoperative pneumonia, respiratory failure, stroke, kidney failure, and wound infection of the sternum. Long-term 5-year and 10-year survival after CABG is lower in patients with COPD. The longterm adverse prognosis depends on the severity of the bronchial obstruction. Achievements in the field of cardiac surgery have had a significant impact on the results of surgical interventions in the comorbid course of CAD and COPD. Intensive pulmonary rehabilitation after surgery and effective drug therapy can improve the outcomes after CABG in patients with COPD. Hybrid coronary revascularization and minimally invasive coronary surgery appear to be viable alternatives to conventional CABG, offering a less invasive approach to coronary revascularization, which may be especially beneficial to high-risk patients with COPD.
Publisher
Far Eastern Scientific Center Of Physiology and Pathology of Respiration
Reference40 articles.
1. Efros LA, Samorodskaya I.V. Features of the structure and the impact of comorbidities on the long-term prognosis after coronary bypass grafting. Byulleten' NTSSSKH im. A.N. Bakuleva RAMN «Serdechno-sosudistyye zabolevaniya» (Bulletin of Bakoulev Center Cardiovascular Diseases) 2013; 14(1):33–41 (in Russian).
2. Barbarash N.L., Semjonov V.Yu., Samorodskaya I.V., Evseeva М.V., Rozhkov N.A., Sumin A.N., Barbarash L.S. Comorbidity in coronary heart disease patients undergoing bypass grafting: an experience of two surgery centers. Russian Journal of Cardiology 2017; (3):6–13 (in Russian). doi: 10.15829/1560-4071-2017-3-6-13
3. Adelborg K., Horváth-Puhó E., Schmidt M., Munch T., Pedersen L., Nielsen P. H., Bøtker H.E., Sørensen H. T. Thirty-year mortality after coronary artery bypass graft surgery: A Danish Nationwide Population-Based Cohort Study. Circ. Cardiovasc. Qual. Outcomes 2017; (10):e002708. doi: 10.1161/CIRCOUTCOMES.116.002708
4. Zhao H., Li L., Yang G., Gong J., Ye L., Zhi S., Zhang X., Li J. Postoperative outcomes of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass grafting surgery. Journal Medicine (Baltimore) 2019; 98(6):e14388. doi: 10.1097/MD.0000000000014388
5. McNeely C., Markwell S., Vassileva C. Trends in patient characteristics and outcomes of coronary artery bypass grafting in the 2000 to 2012 Medicare Population. Ann. Thorac. Surg. 2016; 102(1):132–138. doi: 10.1016/j.athoracsur.2016.01.016